Renal disease and left atrial remodeling predict atrial fibrillation in patients with cardiovascular risk factors

被引:26
|
作者
Sciacqua, Angela [1 ]
Perticone, Maria
Tripepi, Giovanni [2 ]
Miceli, Sofia [1 ]
Tassone, Eliezer J. [1 ]
Grillo, Nadia [1 ]
Carullo, Giuseppe [1 ]
Sesti, Giorgio [1 ]
Perticone, Francesco [1 ]
机构
[1] Magna Graecia Univ Catanzaro, Dept Med & Surg Sci, I-88100 Catanzaro, Italy
[2] CNR, Inst Biomed, Clin Epidemiol & Physiopathol Renal Dis & Hyperte, Reggio Di Calabria, Italy
关键词
Atrial fibrillation; Chronic kidney disease; Atrial volume; Left ventricular hypertrophy; LEFT-VENTRICULAR HYPERTROPHY; KIDNEY-FUNCTION; CARDIAC MASS; HEART; DYSFUNCTION; ECHOCARDIOGRAPHY; HYPERTENSION; CREATININE; OUTCOMES; VOLUME;
D O I
10.1016/j.ijcard.2014.04.259
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: In this prospective population-based study, we tested the possible interaction between chronic kidney disease (CKD) and left atrium volume index (LAVI) in predicting incident atrial fibrillation (AF). Methods: We enrolled 3549 Caucasian subjects, 1829 men and 1720 women, aged 60.7 +/- 10.6 years, without baseline AF and thyroid disorders. Echocardiographic left ventricular mass and LAVI were measured. Renal function was calculated by estimated glomerular filtration rate (e-GFR). To test the effect of some clinical confounders on incident AF, we constructed different models including clinical and laboratory parameters. AF diagnosis was made by standard electrocardiogram or 24-h ECG-Holter, hospital discharge diagnoses, and by the all-clinical documentation. Results: During the follow-up (53.3 +/- 18.1 months), 546 subjects developed AF (4.5 events/100 patient-years). Progressors to AF were older, had a higher body mass index, blood pressure, LDL-cholesterol, glucose, cardiac mass, and LAVI, and had lower e-GFR. Hypertension, metabolic syndrome, diabetes, cardiac hypertrophy and CKD were more common among AF cases than controls. In the final Cox regression model, variables that remained significantly associated with AF were: cardiac hypertrophy (HR = 1.495, 95% CI = 1.215-1.841), renal disease (HR = 1.528, 95% CI = 1.261-1.851), age (HR = 1.586, 95% CI = 1.461-1.725) and LAVI (HR = 2.920, 95% CI = 2.426-3.515). The interaction analysis demonstrated a synergic effect between CKD and cardiac hypertrophy (HR = 4.040, 95% CI = 2.661-6.133), as well as between CKD and LAVI (HR = 4.875, 95% CI = 2.699-8.805). The coexistence of all three subclinical organ damages significantly increases the arrhythmic risk (HR = 7.185, 95% CI = 5.041-10.240). Conclusions: Our data demonstrate that LAVI and CKD significantly interact in a synergic manner in increasing AF risk. (C) 2014 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:90 / 95
页数:6
相关论文
共 50 条
  • [21] Risk of left atrial appendage thrombus in patients with atrial fibrillation and chronic kidney disease
    Budnik, Monika
    Gawalko, Monika
    Gorczyca, Iwona
    Uzieblo-Zyczkowska, Beata
    Krzesinski, Pawel
    Kochanowski, Janusz
    Scislo, Piotr
    Michalska, Anna
    Jelonek, Olga
    Starzyk, Katarzyna
    Jurek, Agnieszka
    Kiliszek, Marek
    Wozakowska-Kaplon, Beata
    Gielerak, Grzegorz
    Filipiak, Krzysztof J.
    Opolski, Grzegorz
    Kaplon-Cieslicka, Agnieszka
    [J]. CARDIOLOGY JOURNAL, 2022, 29 (02) : 205 - 215
  • [22] Left atrial remodelling and thrombotic risk in atrial fibrillation patients
    Chatzikyriakou, S.
    Garcia, E. Silvia
    Geelen, P.
    Peytchev, P.
    De Potter, T.
    [J]. ACTA CARDIOLOGICA, 2017, 72 (05) : 586 - 586
  • [23] Left Atrial Remodeling and Recurrence of Congestive Heart Failure in Patients with Atrial Fibrillation
    Yamaguchi, Kazuto
    Tumenbayar, Maidar
    Yoshitomi, Hiroyuki
    Okada, Taiji
    Nakamura, Taku
    Ito, Shinpei
    Ouchi, Takeshi
    Watanabe, Nobuhide
    Endo, Akihiro
    Tanabe, Kazuaki
    [J]. JOURNAL OF CARDIAC FAILURE, 2016, 22 (09) : S175 - S175
  • [24] Reverse structural left atrial remodeling and atrial tachycardia in patients with repeat ablation for atrial fibrillation
    Hashiguchi, Naotaka
    Chiang, Cheng-Hung
    Rottner, Laura
    Reissmann, Bruno
    Rillig, Andreas
    Maurer, Tilman
    Lemes, Christine
    Kuck, Karl-Heinz
    Ouyang, Feifan
    Mathew, Shibu
    [J]. PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2023, 46 (01): : 11 - 19
  • [25] Risk factors of the atrial fibrillation progression in patients with recurrent atrial fibrillation
    Ganiyev, T. Z. Tohir
    Zakirov, N. U.
    Kurbanov, R. D.
    Irisov, D. B.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2016, 18 : 468 - 468
  • [26] Risk factors for atrial fibrillation in elderly subjects without cardiovascular disease
    Zachariah, D.
    Kalra, P. R.
    Roberts, P. R.
    Foley, R. N.
    [J]. EUROPEAN HEART JOURNAL, 2009, 30 : 562 - 562
  • [27] Impact of Left Ventricular Diastolic Dysfunction on Left Atrial Electrical Remodeling in Patients With Atrial Fibrillation
    Kishima, Hideyuki
    Mine, Takanao
    Fukuhara, Eiji
    Rin, Saikyo
    Ashida, Kenki
    Ishihara, Masaharu
    Masuyama, Tohru
    [J]. CIRCULATION, 2018, 138
  • [28] Atrial fibrillation, an equivalent of cardiovascular disease risk
    Barrios, Vivencio
    Escobar, Carlos
    [J]. EUROPEAN HEART JOURNAL, 2020, 41 (48) : 4599 - 4599
  • [29] Risk factors of left atrial appendage thrombus in patients with non-valvular atrial fibrillation
    Liu, Yaowu
    Zhu, Didi
    Xiao, Yunyun
    Zhu, Yeqian
    Zhou, Qianxing
    Ren, Liqun
    Chen, Long
    [J]. OPEN MEDICINE, 2021, 16 (01): : 361 - 366
  • [30] Risk of Cardiovascular Complications in Patients With Persistent Atrial Fibrillation After Dissolution of a Thrombus in the Left Atrial Appendage
    Mazur, E. S.
    Mazur, V. V.
    Bazhenov, N. D.
    Orlov, Y. A.
    [J]. KARDIOLOGIYA, 2021, 61 (05) : 17 - 22